Clinical Trial Update: Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating eculizumab for hypertensive emergency-associated hemolytic uremic syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertensive Emergency-associated Hemolytic Uremic Syndrome

Drugs mentioned

• Eculizumab (eculizumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Hypertensive Emergency-associated Hemolytic Uremic Syndrome | Phase 3 | Status: RECRUITING